{"id":"esmolol-administration","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Hypotension"},{"rate":"5-10%","effect":"Bradycardia"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL1201115","moleculeType":"Small molecule","molecularWeight":"331.84"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Esmolol is a selective beta-1 adrenergic receptor antagonist that reduces heart rate and blood pressure.","oneSentence":"Beta-1 adrenergic receptor antagonist","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:51:50.352Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Tachyarrhythmias"}]},"trialDetails":[{"nctId":"NCT07313605","phase":"PHASE1, PHASE2","title":"POCUS-Guided Esmolol in Septic Shock: A Pilot RCT","status":"NOT_YET_RECRUITING","sponsor":"John Basmaji","startDate":"2026-01-15","conditions":"Septic Shock","enrollment":100},{"nctId":"NCT06863558","phase":"PHASE3","title":"Reduction of Edema With a Specialized Cocktail for Ultra-early Management in Intracerebral Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-05-08","conditions":"Intracerebral Hemorrhage","enrollment":58},{"nctId":"NCT06683911","phase":"","title":"Opioids Continue to Play a Primary Role in the Management of Perioperative Pain Due to Opioid-Free Anesthesia in Open Heart Surgery.","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2024-04-03","conditions":"Undergoing Open-Heart Surgery","enrollment":98},{"nctId":"NCT06958393","phase":"PHASE4","title":"Effect of Opioid-free Anaesthesia on Postoperative Delirium in Elderly Patients Undergoing Gastrointestinal Surgery","status":"NOT_YET_RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2025-05-20","conditions":"Delirium - Postoperative, Opioid-Free Anaesthesia","enrollment":406},{"nctId":"NCT06863571","phase":"PHASE3","title":"Reduction of Edema With a Specialized Cocktail for Ultra-early Management in Ischemic Stroke","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-04-12","conditions":"Ischemic Stroke","enrollment":68},{"nctId":"NCT02098629","phase":"PHASE2","title":"Concomitant Milrinone and Esmolol Treatment in Patients with Acute Myocardial Infarction","status":"COMPLETED","sponsor":"Shantou University Medical College","startDate":"2015-05","conditions":"Myocardial Reperfusion Injury","enrollment":25},{"nctId":"NCT06635707","phase":"","title":"Efficacy and Safety Study of Urapidil Alone or With Esmolol in Treating Acute Hypertensive Intracerebral Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2024-11-01","conditions":"Hypertensive Intracerebral Hemorrhage","enrollment":600},{"nctId":"NCT05769868","phase":"PHASE3","title":"Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments","status":"RECRUITING","sponsor":"Consorcio Centro de Investigación Biomédica en Red (CIBER)","startDate":"2023-04-18","conditions":"Cirrhosis, Diabetes Mellitus, Oncologic Disorders","enrollment":1000},{"nctId":"NCT04356352","phase":"PHASE2, PHASE3","title":"Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain","status":"TERMINATED","sponsor":"Wake Forest University Health Sciences","startDate":"2020-09-09","conditions":"Injection Site Irritation, Pain","enrollment":33},{"nctId":"NCT06291363","phase":"PHASE4","title":"Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception.","status":"RECRUITING","sponsor":"Ciusss de L'Est de l'Île de Montréal","startDate":"2024-04-16","conditions":"Opioid Use, Unspecified, Anesthesia, Nociceptive Pain","enrollment":64},{"nctId":"NCT06390748","phase":"PHASE2","title":"Esmolol in Sepsis Management:Evaluating Immunomodulatory Effects and Impact on Patient Outcomes","status":"COMPLETED","sponsor":"Lin Chen","startDate":"2021-01-01","conditions":"Sepsis, Lymphocyte Disorder T, Immunologic Paralysis","enrollment":150},{"nctId":"NCT01113515","phase":"PHASE1, PHASE2","title":"Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"Novalead Pharma Private Limited","startDate":"2014-02-20","conditions":"Diabetic Foot Ulcer","enrollment":44},{"nctId":"NCT03549923","phase":"PHASE4","title":"Evaluation of Early CRRT InTerventions in Patients With ECMO(ELITE)","status":"COMPLETED","sponsor":"Beijing Anzhen Hospital","startDate":"2018-12-18","conditions":"Cardiogenic Shock","enrollment":131},{"nctId":"NCT06376630","phase":"NA","title":"Study of Microvascular Dysfunction, CFR and Cardioprotective Effect of Early Administration of Esmolol in MI","status":"RECRUITING","sponsor":"National Medical Research Center for Cardiology, Ministry of Health of Russian Federation","startDate":"2024-01-29","conditions":"Myocardial Infarction, Coronary Stenosis, Coronary Microvascular Dysfunction","enrollment":300},{"nctId":"NCT06013319","phase":"PHASE3","title":"Effect of Esmolol on Oxygenation Index in Patients With Acute Respiratory Distress Syndrome","status":"RECRUITING","sponsor":"Zhiming Jiang","startDate":"2023-02-20","conditions":"Acute Respiratory Distress Syndrome","enrollment":178},{"nctId":"NCT03998436","phase":"PHASE3","title":"Phase 3 Study to Evaluate the Safety and Efficacy of Galnobax® in Treating Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"Novalead Pharma Private Limited","startDate":"2018-12-26","conditions":"Diabetic Foot Ulcer","enrollment":176},{"nctId":"NCT02120404","phase":"PHASE2","title":"Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic Shock","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-04","conditions":"Septic Shock","enrollment":45},{"nctId":"NCT05635877","phase":"PHASE4","title":"Effects of Low-dose Esmolol on Myocardial Injury After Non-cardiac Surgery in Elderly Frail Patients","status":"RECRUITING","sponsor":"Yongtao Sun","startDate":"2023-02-07","conditions":"Frailty, Esmolol, Myocardial Injury","enrollment":2000},{"nctId":"NCT03743103","phase":"PHASE4","title":"Esmolol for the Treatment of Hypertension After Intracerebral Hemorrhage Study (ETHICHS)","status":"TERMINATED","sponsor":"Cristália Produtos Químicos Farmacêuticos Ltda.","startDate":"2019-04-18","conditions":"Hemorrhagic Stroke","enrollment":20},{"nctId":"NCT05567822","phase":"NA","title":"The Impact of Esmolol Administration on Postoperative Recovery","status":"UNKNOWN","sponsor":"Aretaieion University Hospital","startDate":"2022-10-01","conditions":"Pain, Acute, Pain, Postoperative, Pain, Chronic Post-Surgical","enrollment":70},{"nctId":"NCT01422616","phase":"PHASE3","title":"Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)","status":"COMPLETED","sponsor":"The George Institute","startDate":"2012-03","conditions":"Ischemic Stroke, High Blood Pressure","enrollment":4587},{"nctId":"NCT04752111","phase":"PHASE4","title":"Dose Esmolol Infusion Have an Adjuvant Effect to TAP Block for Pain Control in Laparoscopic Cholecystectomy.","status":"COMPLETED","sponsor":"Benha University","startDate":"2021-01-19","conditions":"Postoperative Pain","enrollment":60},{"nctId":"NCT02369900","phase":"PHASE2","title":"Esmolol to Treat the Hemodynamic Effects of Septic Shock","status":"TERMINATED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2015-03","conditions":"Septic Shock, Hypotension, Tachycardia","enrollment":40},{"nctId":"NCT04046068","phase":"","title":"Multimodal Perioperative Pain Management: ComfortSafe Program","status":"UNKNOWN","sponsor":"Georgetown University","startDate":"2020-05-11","conditions":"Post-operative Pain, Post-operative Nausea and Vomiting, Respiratory Depression","enrollment":60},{"nctId":"NCT01114971","phase":"PHASE4","title":"Labetalol and Esmolol: Vital Signs and Post Operative Pain Management","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2009-09-03","conditions":"Laparoscopic Surgery","enrollment":75},{"nctId":"NCT02116868","phase":"NA","title":"Pupillary Reflex Measurement to Guide Intraoperative Analgesia During Laparoscopic Surgery","status":"COMPLETED","sponsor":"Central Hospital, Nancy, France","startDate":"2014-03","conditions":"Scheduled Laparoscopic Surgery","enrollment":100},{"nctId":"NCT02327923","phase":"PHASE4","title":"Intraoperative Lidocaine Infusion vs. Esmolol Infusion for Postoperative Analgesia in Laparoscopic Cholecystectomy","status":"COMPLETED","sponsor":"B.P. Koirala Institute of Health Sciences","startDate":"2015-01","conditions":"Gall Stone Disease","enrollment":90},{"nctId":"NCT00756236","phase":"NA","title":"A Comparison of the Effects of Intraoperative Administration of Metoprolol or Esmolol on General Anesthetic Requirement","status":"COMPLETED","sponsor":"University of Oklahoma","startDate":"2008-10","conditions":"Myocardial Ischemia","enrollment":60},{"nctId":"NCT01114997","phase":"PHASE4","title":"Effect of Lidocaine and Esmolol to Improve the Quality of Recovery","status":"TERMINATED","sponsor":"Cedars-Sinai Medical Center","startDate":"2010-04","conditions":"Pain, Constipation, Nausea","enrollment":32},{"nctId":"NCT01179113","phase":"PHASE4","title":"Esmolol Infusion During Laminectomy: Effect on Quality of Recovery","status":"TERMINATED","sponsor":"Cedars-Sinai Medical Center","startDate":"2011-06","conditions":"Laminectomy","enrollment":33},{"nctId":"NCT00922467","phase":"PHASE3","title":"Influence of Esmolol on a Closed-Loop Anesthesia System","status":"TERMINATED","sponsor":"Hopital Foch","startDate":"2009-06","conditions":"Anesthesia","enrollment":15},{"nctId":"NCT02842983","phase":"PHASE2, PHASE3","title":"Pilot Study: Echocardiographic and Hemodynamic Effects of Esmolol in Septic Shock Patients","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2014-12","conditions":"Shock, Septic","enrollment":36},{"nctId":"NCT02068287","phase":"PHASE2","title":"Esmolol Effects on Heart and Inflammation in Septic Shock","status":"UNKNOWN","sponsor":"Central Hospital, Nancy, France","startDate":"2013-12","conditions":"Septic Shock","enrollment":25},{"nctId":"NCT01741519","phase":"PHASE1","title":"Long-term PK and Safety/Tolerability Testing LDLL600 Against Esmolol in Healthy Volunteers","status":"COMPLETED","sponsor":"AOP Orphan Pharmaceuticals AG","startDate":"2012-12","conditions":"Healthy","enrollment":14},{"nctId":"NCT01404767","phase":"PHASE4","title":"Tight Hemodynamic Control in Patients Who Are Chronically on Metoprolol","status":"TERMINATED","sponsor":"University Health Network, Toronto","startDate":"2011-04","conditions":"Vascular Disease, Hypertension, Angina","enrollment":20},{"nctId":"NCT01208402","phase":"PHASE3","title":"Esmolol for Treatment of Perioperative Tachycardia","status":"TERMINATED","sponsor":"Duke University","startDate":"2010-09","conditions":"High-risk, Non-cardiovascular Surgeries","enrollment":76},{"nctId":"NCT01951950","phase":"PHASE1","title":"Nicardipine vs Esmolol Craniotomy Emergence","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2013-09","conditions":"Brain Tumors","enrollment":40},{"nctId":"NCT00716079","phase":"NA","title":"The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial","status":"COMPLETED","sponsor":"The George Institute","startDate":"2008-09","conditions":"Intracerebral Hemorrhage, Stroke, Hypertension","enrollment":2839},{"nctId":"NCT01231698","phase":"PHASE2","title":"Heart Rate Control With Esmolol in Septic Shock","status":"COMPLETED","sponsor":"Andrea Morelli","startDate":"2010-12","conditions":"Septic Shock","enrollment":154},{"nctId":"NCT01652898","phase":"PHASE1","title":"A Pharmacokinetic, Pharmacodynamic, Safety Study With AOP LDLA202, ONO LDL50 and Esmolol in Healthy Volunteers","status":"COMPLETED","sponsor":"AOP Orphan Pharmaceuticals AG","startDate":"2012-07","conditions":"Healthy","enrollment":12},{"nctId":"NCT01313143","phase":"PHASE2","title":"A Short Term Pharmacokinetic, Pharmacodynamic and Tolerability Study to Compare AOP200704 vs. Esmolol","status":"COMPLETED","sponsor":"AOP Orphan Pharmaceuticals AG","startDate":"2011-03","conditions":"Healthy Volunteers, Pharmacokinetics/Dynamics Study","enrollment":16},{"nctId":"NCT01431612","phase":"PHASE1, PHASE2","title":"Effects of Adrenergic Drugs on the Fluid Balance During Surgery","status":"COMPLETED","sponsor":"Sodertalje Hospital","startDate":"2008-11","conditions":"Ovarian Cyst","enrollment":60},{"nctId":"NCT01279499","phase":"PHASE2, PHASE3","title":"Sevoflurane Versus Intravenous Anaesthetic Agents in Morbid Obese Patients","status":"UNKNOWN","sponsor":"University of Patras","startDate":"2010-04","conditions":"Morbid Obesity","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":65,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["BREVIBLOC 10 mg/ml","Drug by Qilu Pharmaceutical Co, Shandong, China"],"phase":"phase_2","status":"active","brandName":"Esmolol administration","genericName":"Esmolol administration","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Beta-1 adrenergic receptor antagonist Used for Hypertension, Tachyarrhythmias.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}